Patents by Inventor Cheryl M. Hayward

Cheryl M. Hayward has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Piperidine compounds useful as PPAR activators
    Patent number: 7199243
    Abstract: PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans.
    Type: Grant
    Filed: November 24, 2003
    Date of Patent: April 3, 2007
    Assignees: Pfizer Inc., Pfizer Products Inc.
    Inventors: Scott W. Bagley, Thomas A. Brandt, Robert W. Dugger, William A. Hada, Cheryl M. Hayward, Zhengyu Liu
  • PPAR activators
    Publication number: 20040157885
    Abstract: PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans.
    Type: Application
    Filed: November 24, 2003
    Publication date: August 12, 2004
    Applicant: Pfizer Inc
    Inventors: Scott W. Bagley, Thomas A. Brandt, Robert W. Dugger, William A. Hada, Cheryl M. Hayward, Zhengyu Liu
  • PPAR agonists
    Patent number: 6699904
    Abstract: PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans.
    Type: Grant
    Filed: February 14, 2002
    Date of Patent: March 2, 2004
    Assignee: Pfizer Inc.
    Inventors: Cheryl M. Hayward, David A. Perry
  • 4,1-benzoxazepines or 4,1-benzothiazepines and their use as squalene synthetase inhibitors
    Patent number: 6537987
    Abstract: This invention relates to certain benzoxazepinones and benzothiazepinones useful as hypocholesterolemic agents, hypotriglyceridemic agents, antiatherosclerosis agents, antifungal agents, anti-Alzheimer's agents or anti-acne agents.
    Type: Grant
    Filed: December 18, 1998
    Date of Patent: March 25, 2003
    Assignee: Pfizer Inc.
    Inventors: Ernest S. Hamanaka, Cheryl M. Hayward
  • PPAR compounds
    Publication number: 20020169192
    Abstract: PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans.
    Type: Application
    Filed: February 14, 2002
    Publication date: November 14, 2002
    Inventors: Cheryl M. Hayward, David A. Perry
  • PPAR agonists
    Publication number: 20020165282
    Abstract: PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans.
    Type: Application
    Filed: February 14, 2002
    Publication date: November 7, 2002
    Inventors: Cheryl M. Hayward, David A. Perry
  • Squalene synthetase inhibitor agents
    Patent number: 6207664
    Abstract: This invention relates to certain squalene synthetase inhibitors useful as hypocholesterolemic agents, hypotriglyceridemic agents, antiatherosclerosis agents, antifungal agents, anti-Alzheimer's agents or anti-acne agents.
    Type: Grant
    Filed: November 16, 1999
    Date of Patent: March 27, 2001
    Assignee: Pfizer Inc.
    Inventors: Cheryl M. Hayward, Douglas A. Scully
  • Squalene synthetase inhibitors
    Patent number: 5965553
    Abstract: This invention relates to certain benzoxazepinones and benzothiazepinones useful as hypocholesterolemic agents, hypotriglyceridemic agents, antiatherosclerosis agents, antifungal agents, Alzheimer's agents or anti-acne agents.
    Type: Grant
    Filed: June 12, 1997
    Date of Patent: October 12, 1999
    Assignee: Pfizer Inc.
    Inventors: Andrew S. Bell, Ernest S. Hamanaka, Cheryl M. Hayward, Douglas A. Scully, Blanda Stammen
  • Naphthyl-benzoxazepines or -benzothiazepines as squalene synthetase inhibitors
    Patent number: 5770594
    Abstract: This invention relates to certain benzoxazepinones and benzothiazepinones useful as hypocholesterolemic agents and antiatheroscierosis agents.
    Type: Grant
    Filed: June 17, 1997
    Date of Patent: June 23, 1998
    Assignee: Pfizer Inc.
    Inventors: Ernest S. Hamanaka, Cheryl M. Hayward, Joel M. Hawkins